Healthtech Series B Investors & VC Firms
1027 firms in this list, with a median first check of $540K. 256 of them lead rounds. Generated from verified public data and updated continuously.
Sheares Healthcare Group
SingaporeSeed–Late Stage
CIBC
TorontoPre-Seed–Late Stage$1.5M – $29.2M
1 person
165 Ventures
Seed–Growth
Action Potential Venture Capital Ltd.
Scotts ValleySeed–Late Stage
3 people
China Renaissance – Huaxing New Economy Funds
BeijingSeed–Growth
IMM Investment
KangnamPre-Seed–Growth
Namibia Development Bank
WindhoekSeed–Late Stage
Deloitte Ventures
TorontoSeed–Growth
2 people
GBS Venture Partners Ltd.
MelbourneSeed–Growth$165K – $7.9M
2 people
Australian Unity Future of Healthcare Fund
MelbourneSeries A–Growth
CDF-Capital
ShenzhenSeed–Late Stage
GEA Capital
Guatemala CitySeed–Growth
Haier Capital
ShanghaiSeed–Growth
K2 Global
WilmingtonPre-Seed–Series C
3 people
Laval Innov
LavalPre-Seed–Late Stage
National Development Fund of Taiwan Government
TaipeiSeed–Growth
NIPPON EXPRESS HOLDINGS
Seed–Series B
Point32Health Ventures
CantonSeries A–Late Stage
RKCA
CincinnatiPre-Seed–Late Stage
Teewinot Ventures
Pre-Seed–Late Stage
Exor
AmsterdamSeries A–Series B
1 person
Annox Capital
BirminghamSeed–Growth$100K – $30M
1 person
Alive Ventures
BogotáSeries A–Growth
2 people
Bioeconomy
SeattleSeed–Series B
4 people
Related lists
Healthtech Investors & VC Firms (4190)Healthtech Seed Investors & VC Firms (3233)Series B Investors & VC Firms (2946)Healthtech Investors & VC Firms in North America (2665)Healthtech Investors & VC Firms in United States (2436)Healthtech Series A Investors & VC Firms (2309)Series B Investors & VC Firms in North America (1736)Series B Investors & VC Firms in United States (1571)Healthtech Pre-Seed Investors & VC Firms (1468)Healthtech Investors & VC Firms in Europe (1357)
Data sourced from public filings and firms' own websites — see our methodology.









